Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 2 | 2023 | 406 | 1.180 |
Why?
|
| Immunotherapy | 4 | 2024 | 688 | 0.840 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2023 | 394 | 0.730 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 1221 | 0.670 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 604 | 0.660 |
Why?
|
| Melanoma | 1 | 2023 | 467 | 0.640 |
Why?
|
| Antigen Presentation | 1 | 2018 | 215 | 0.570 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 516 | 0.540 |
Why?
|
| Skin | 1 | 2018 | 589 | 0.490 |
Why?
|
| Lipids | 2 | 2023 | 275 | 0.330 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2023 | 173 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2024 | 597 | 0.290 |
Why?
|
| Immune System | 2 | 2023 | 97 | 0.230 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2023 | 5 | 0.220 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 61 | 0.220 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 30 | 0.220 |
Why?
|
| Germ-Free Life | 1 | 2023 | 75 | 0.210 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2023 | 69 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 2384 | 0.210 |
Why?
|
| Down-Regulation | 1 | 2023 | 520 | 0.190 |
Why?
|
| Protein Binding | 2 | 2023 | 1491 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2023 | 433 | 0.170 |
Why?
|
| Mice | 7 | 2024 | 11828 | 0.170 |
Why?
|
| Animals | 9 | 2024 | 27476 | 0.170 |
Why?
|
| Antigens, CD1 | 1 | 2018 | 37 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 84 | 0.150 |
Why?
|
| Models, Immunological | 1 | 2018 | 81 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 45 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 523 | 0.150 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2018 | 32 | 0.150 |
Why?
|
| Antigens | 1 | 2018 | 229 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2018 | 3395 | 0.140 |
Why?
|
| Inflammation | 3 | 2018 | 975 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 273 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2015 | 57 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2015 | 98 | 0.120 |
Why?
|
| Oncolytic Virotherapy | 1 | 2014 | 42 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 276 | 0.110 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 278 | 0.110 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2012 | 19 | 0.110 |
Why?
|
| CD28 Antigens | 1 | 2012 | 90 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2023 | 754 | 0.100 |
Why?
|
| Neoplasms | 2 | 2024 | 3053 | 0.100 |
Why?
|
| Humans | 6 | 2024 | 89567 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 447 | 0.070 |
Why?
|
| Formates | 1 | 2023 | 7 | 0.060 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2023 | 8 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 135 | 0.050 |
Why?
|
| NAD | 1 | 2023 | 72 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 35 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2023 | 124 | 0.050 |
Why?
|
| Phosphates | 1 | 2023 | 161 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1576 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 388 | 0.050 |
Why?
|
| Age Factors | 1 | 2024 | 1877 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 476 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 721 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2582 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2018 | 67 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2018 | 66 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 37 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 123 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 3237 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2018 | 241 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 150 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2018 | 285 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 269 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2018 | 169 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 333 | 0.030 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2015 | 4 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 16 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1130 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 98 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 98 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2015 | 216 | 0.030 |
Why?
|
| Newcastle disease virus | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 200 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2014 | 24 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2014 | 140 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 397 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 466 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 111 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1158 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2012 | 18 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2014 | 186 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 276 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 142 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 312 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2014 | 468 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1273 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 952 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 446 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 449 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1309 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2012 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1982 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2447 | 0.020 |
Why?
|
| Female | 2 | 2024 | 46371 | 0.020 |
Why?
|
| Male | 1 | 2012 | 42464 | 0.010 |
Why?
|